Tau as a potential novel therapeutic target in ischemic stroke

Authors

  • Guo-Qing Zheng,

    Corresponding author
    1. Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325027, China
    • Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical College, 109 Xueyuan West Road, Wenzhou 325027, China.
    Search for more papers by this author
  • Xiu-Min Wang,

    1. Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325027, China
    Search for more papers by this author
  • Yan Wang,

    1. Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325027, China
    Search for more papers by this author
  • Xiao-Tong Wang

    Corresponding author
    1. Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325027, China
    • Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical College, 109 Xueyuan West Road, Wenzhou 325027, China.
    Search for more papers by this author

Abstract

Stroke is associated with high mortality and major disability burdens worldwide, but there are few effective and widely available therapies. Tau plays an important role in promoting microtubule assembly and stabilizing microtubule networks with phosphorylation regulating these functions. Based on the “ischemia-reperfusion theory” of Alzheimer's disease, some previous studies have focused on the relationship of tau and Alzheimer lesions in experimental brain ischemia. Thus, we hypothesize that the alterations in phosphorylation of tau are critical to microtubule dynamics and metabolism, and contribute to the pathophysiologic mechanisms during brain ischemia and/or reperfusion processes. We infer that regulation of phosphorylation of tau may be considered as a potential new therapeutic target in ischemic stroke. J. Cell. Biochem. 109: 26–29, 2010. © 2009 Wiley-Liss, Inc.

Ancillary